At the practice of Blossom Inuenwi, DNP, APRN, ACNS-BC, FNP-C, patients receive individualized guidance to understand whether GLP-1 therapy is a suitable option based on their health needs, lifestyle, and wellness objectives
This requires risk-stratified prescription strategies targeting individuals with the greatest risk of complications or those most likely to benefit based on predictive biomarkers
Three things worth considering: - Normal-looking biomarkers on medication are not the same as metabolic health
Its not just about hitting a certain gram count
These may indicate serious conditions such as pancreatitis or gallbladder disease, which have been associated with the GLP-1 drug class
within the first 24 h) and permanent 35